Content area


Surgical treatment of patulous Eustachian tube – a systematic review


Zaid Mousa1, 2, Christian Faber1 & Tine Rosenberg1, 2

1) Research Unit for Department of ORL - Head & Neck Surgery and Audiology, Odense University Hospital, 2)

Faculty of Health Sciences, University of Southern Denmark, Denmark

Dan Med J 2020;67(10):A02200068


INTRODUCTION:Patulous Eustachian tube (PET) seems to be caused by a defect in the mucosal valve of the Eustachian tube. It causes troublesome autophony occasionally leading to an impaired quality of life. In the present study, we aimed to evaluate the effect of surgical treatment of PET through a systematic review of published studies.

METHODS: A systematic review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis statement. Medline, Embase and Cochrane were searched systematically for publications about PET.

METHODS: Fourteen publications counting a total of 510 ears from 390 patients who had been treated surgically for PET were included. Complete relief of symptoms ranged from 7% to 77%, improvement from 7% to 86% and 0% to 41% had no response. No studies reported aggravation of symptoms.

CONCLUSIONS: A number of suggested treatments appear to be promising for PET, but it is difficult to propose a specific surgical treatment due to low numbers of patients, lack of clinical trials and cohort studies without control groups.

Key points

  • Patulous Eustachian tube (PET) is an underdiagnosed condition with insufficient data on appropriate

  • Conservative treatment is not always sufficient for PET.

  • Various surgical treatment options for PET have been proposed; some have shown promising results.

  • This review attempts to identify weaknesses and suggests methods to improve the quality of future
    studies for surgical treatment of PET.

The Eustachian tube is involved in the normal physiology of the (middle) ear by serving as an opening that drains the middle ear from secretions and facilitates ventilation. Two centuries ago, it was generally believed that the Eustachian tube was always open. However, in 1853, Toynbee proposed that the tube is passively closed and opens only briefly by contraction of two muscles named the tensor and levator veli palatini [1]. It was discovered that the purpose of this contraction is to prevent sound transmission from the pharynx to the ears when talking or breathing and to stop reflux of secretions from the nasopharynx to the middle ear. In a healthy ear, the tube opens briefly by action of the two muscles during activities such as swallowing or yawning. The tube may also open as a result of applied pressure, for instance when performing the Valsalva manoeuvre or during sneezing [2, 3]. In patulous Eustachian tube (PET), the tube is chronically open.

The most reported risk factor for PET is weight loss [4, 5]. The risk also increases during pregnancy. A Danish study from 1979 examined 270 pregnant women among whom a total of 19 women were found to have PET. This number was significantly higher than in a control group [6].

The primary symptom in PET is voice and breath autophony, where nasal voice and nasal respiration, in particular, constitute the most bothersome symptoms. Another major symptom is aural fullness (sensation of blockage in the ear). Patients may also suffer from tinnitus or vertigo [7]. It was reported that exercise and use of nasal decongestant aggravate the symptoms [8], while lying down or sniffing reduces the symptoms [9].

In 1988, Bluestone & Doyle suggested that reflux of nasopharyngeal contents due to a chronically open Eustachian tube could cause otitis media [2]. In another study by Oshima et al from 2011, it was demonstrated that cholesteatoma was more common in patients with PET due to habitual sniffing which relieves PET symptoms but causes retraction of the tympanic membrane. The authors compared two cohorts: one consisting of 97 patients with “sniff-positive PET” and another cohort consisting of 39 patients with “sniff-negative PET”. Cholesteatoma (or signs of previous cholesteatoma) was noticed in five of the “sniff-positive patients”, whereas in the “sniff-negative PET” group, there were no signs of present or previous cholesteatoma [10]. In addition, a similar study from 2009 suggested that the incidence of PET in patients with cholesteatoma was significantly higher than in patients with other ear conditions such as chronic otitis media or otosclerosis [11]. Another study from 2013 also demonstrated an increased incidence of cholesteatoma in patients with habitual sniffing [12].

In 2018, Japan’s Otological Society proposed a set of diagnostic criteria for PET [13]. According to these criteria, the diagnosis should be based on three criteria; symptoms, symptom relief and objective findings. The first criterion is mandatory for the diagnosis. If a patient meets all three criteria, the diagnosis may be considered confirmed. If a patient meets only two criteria (symptoms and symptom relief or objective findings), the diagnosis is not confirmed but possible, and further examinations are required. In asymptomatic patients, symptoms should be provoked before examination, e.g., by instructing the patients to take a brisk walk, taking heavy nasal breaths, swallowing or performing the Valsalva manoeuvre [8]. In 2007, D.S. Poe suggested a simple five-grade table to evaluate the outcome after treatment; worsening, unchanged, improved and satisfied, improved but dissatisfied or complete remission of symptoms. These are known as Poe’s criteria [8].

PET is an uncommon condition. It can be refractive to conservative treatment (such as weight gain and information about the condition) [14]. Moreover, weight gain might be ill-advised in case of comorbidity. Therefore, there seems to be an indication for surgical treatment in the more affected patients. The intention of surgical treatment is to narrow the tube (tubaplasty) or make the ear drum less compliant to vibration (myringoplasty or myringotomy).

The aim of this study was to perform a systematic review focusing on treatments of PET according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) statement.


We conducted a systematic review following the PRISMA guidelines [15]. The review was registered in the PROSPERO International Prospective Register of Systematic Reviews. The registration number is CRD42018095791.

Systematic literature search

A modified Population, Intervention, Outcome, and Study design (PICOS – PIOS) strategy was employed for the search. The target population consisted of patients with PET and the intervention was surgical treatment. The outcome measures were subjective patient evaluation of autophony and aural fullness changes after surgical treatment. The study design was without restrictions, provided original data were used.

We searched for studies from the electronic bibliographic databases Medline, Embase and Cochrane. The search was conducted on 30 April 2019 and was without restriction on publication date. The search strategy was based on a combination of all available free text terms for PET. The electronic search was performed by the first author (ZM).

Study selection

Duplicates in the literature search were removed manually. The eligibility process was conducted in two steps. First, two authors (ZM and TR) screened the titles and abstracts independently using predefined criteria for inclusion and exclusion. Subsequently, the same two authors independently evaluated the full-text version of any publications that had passed through the first steps. At each step, discrepancies were resolved by discussion or, if needed, CF served as an arbitrator. In case of doubt, the study passed to the next level. We included all studies written in English, Swedish, Norwegian or Danish and providing original data for a minimum of five patients surgically treated for PET. Case reports (n < 5 patients), conference abstracts and publications without relevant data were excluded.

Data items and collection process

ZM performed the data extraction. For each study, we extracted the number of ears and/or patients, gender distribution, follow-up time, complications and outcomes. We inserted outcomes in one of three groups – “complete remission”, “improved” or “no response”. Moreover, data were extracted for symptoms and diagnostic methods.

Risk of bias assessment

Risk of bias in the included studies was assessed using the SIGN Checklist for Cohort Studies [16]. The quality of each study was evaluated according to three domains; selection of subjects, study design and statistics.

Data synthesis

A descriptive synthesis was conducted, summarising diagnostic methods, surgical approach, follow-up, complications and subjective patient-reported outcome of surgical treatment.


Study selection and characteristics

The systematic literature search produced 412 publications (n = 233 after removal of duplicates). The study selection process is shown in Figure 1. A total of 48 publications were analysed as full text; 14 of these studies were included in the quantitative synthesis. Study characteristics are summarised in Table 1.




Risk of bias assessment

According to the SIGN recommendations, three domains were assessed for each included study yielding a total of 42 assessments. The overall assessment was acceptable for all studies.

Synthesis of results

A total of 510 ears (390 patients) were treated surgically. The outcome was presented for each treated ear (or patient) based on a subjective report of post-operative symptoms. The outcome for patients or ears was as follows; complete relief of symptoms ranged from 7% to 77%, improvement from 7% to 86% and no response ranged from 0% to 41%. None of the studies presented patients with aggravation of symptoms. The average follow-up time ranged from one to 29 months. Data are presented in Table 1. Out of 510 treated ears, a minimum of 127 complications were observed. Complications were observed in nine of the 14 trials. Four trials reported no complications and one trial did not specify whether there were complications or not. One of the nine studies reporting complications did not specify how many [17]. Complications for each trial are presented in Table 1. We also divided the 14 trials by type of treatment. Twelve focused on tuboplasties [8, 17-27] and two on myringoplasties [28, 29]. In the tuboplasty trials, accounting for a total of 471 ears, 127 complications occurred, which corresponds to a 27% risk. In the two myringoplasty trials, comprising 39 ears, no complications were observed.


In the present study, we aimed to estimate the effect of surgical treatment for PET. We conducted a systematic literature search and found that a majority of patients benefited from surgical treatment. In total, we identified 14 studies with promising results and few serious complications. In many cases, the outcome was excellent, but the studies had a low evidence level. More and larger studies are needed.

The studies included in this review contained very few ears (a total of 510 ears, of which 252 were from one study alone) and only one study had a control group [28]. This study compared paper patching of the Eustachian tube with standard treatment at their department; saline irrigation. The authors showed that after three months, 65% of the patients treated with paper patching reported to be free of PET symptoms and 26% reported an improvement in symptoms. In the group receiving nasal saline irrigation, only 25% reported symptom relief, and 13% reported improvement after three months [28].

In most studies, complications resolved spontaneously and required only simple or no treatment. The complications are listed in Table 1. A few possibly serious complications were observed. There was a case of mastoiditis in a study by Oh et al. The authors treated 35 ears with transtympanic catheter insertion into the Eustachian tube. Five patients suffered from otitis media after the procedure, three resolved spontaneously and two were treated with ventilation tube for one year. One of the patients treated with a ventilation tube subsequently suffered from mastoiditis, and the decision was made to remove the catheter completely. Furthermore, in three cases, the tube was missing during follow-up; it had probably displaced into the nasopharynx [18]. In 2016, a large study was published comprising 252 ears treated using a transtympanic catheter. A total of 113 complications were reported; 26 of these were catheter displacements into the nasopharynx [19]. In the two studies on transtympanic catheter insertions, a total of 29 catheters in 287 ears were displaced into the nasopharynx.

In a case series published in 2011 involving curvature inversion tubaplasty, complete remission was observed in 45.4% at six-month follow-up (satisfaction was reported by 73% of the patients). After 24 months, complete remission was reported by 73% (satisfaction was reported by 82% of the patients) [20]. In contrast, a study from 2019, which involved paper patching of the tympanic membrane, 83% reported complete remission at the one-month follow-up, but only 65% after three months [28]. This stresses the importance of a sufficiently long follow-up.

The previously mentioned study from 2019 that involved paper patching of the tympanic membrane [28] is the only study included in this review that had a control group. It consisted of patients treated with nasal saline irrigation. In this trial, sterilised cigarette paper was placed in the most mobile qudrant of the tympanic membrane when observed during nasal respiration. The procedure did not lead to any complications. Furthermore, it is non invasive, does not require general anaesthesia and can be performed in an outpatient setting. However, the study included only 23 patients.


A number of suggested treatments appear to be promising for treatment of PET, but a specific surgical treatment is difficult to propose due to low numbers of patients, lack of clinical trials and cohort studies without control groups. Based on this literature review, we suggest that the follow-up time should be at least one year in future studies. Future studies should be properly conducted, preferably duly controlled clinical trials with sufficient sample sizes. There is no generally accepted treatment for the condition. We suggest ventilation tube insertion or paper patching of the tympanic membrane [28] due to the low risk of complications, low cost and ease of application.

Correspondence: Zaid Mousa. E-mail:
Accepted: 22 June 2020
Conflicts of interest: none. Disclosure forms provided by the authors are available with the full text of this article at

Bib ref: 
Dan Med J 2020;67(10):A02200068


  1. Toynbee J. On the muscles which open the eustachian tube. Abstracts of the Papers Communicated to the Royal Society of London 1854;6:286-7.

  2. Bluestone CD, Doyle WJ. Anatomy and physiology of eustachian tube and middle ear related to otitis media. J Allergy Clin Immun 1988;81:997-1003.

  3. Taylor D. The Valsalva manoeuvre: a critical review. J South Pac Underwater Med Soc 1996;26:8-13.

  4. Ward BK, Ashry Y, Poe DS. Patulous eustachian tube dysfunction: patient demographics and comorbidities. Otol Neurotol 2017;38:1362-9.

  5. Pulec JL. Abnormally patent eustachian tubes: treatment with injection of polytetrafluoroethylene (Teflon) paste. Laryngoscope 1967;77:1543-54.

  6. Plate S, Johnsen NJ, Pedersen SN et al. The frequency of patulous Eustachian tubes in pregnancy. Clin Otolaryng Allied Sci 1979;4:393-400.

  7. O'Connor AF, Shea JJ. Autophony and the patulous Eustachian tube. Laryngoscope 1981;91:1427-35.

  8. Poe DS. Diagnosis and management of the patulous eustachian tube. Otol Neurotol 2007;28:668-77.

  9. Thaler S, Yanagisawa E. The abnormally patent eustachian tube. Arch otolaryngol 1966;84:418-21.

  10. Oshima T, Oshima H, Miyazaki M et al. Management of patulous eustachian tube with habitual sniffing. Otol Neurotol 2011;32:790-3.

  11. Ohta S, Sakagami M, Suzuki M et al. Eustachian tube function and habitual sniffing in middle ear cholesteatoma. Otol Neurotol 2009;30:48-53.

  12. Takizawa Y, Mizuta K, Hamada N et al. Relationship between tympanic membrane retraction and habitual sniffing in patients with cholesteatoma. Acta OtoLaryngol 2013;133:1030-4.

  13. Kobayashi T, Morita M, Yoshioka S et al. Diagnostic criteria for patulous Eustachian tube: a proposal by the Japan Otological Society. Auris Nasus Larynx 2018;45:1-5.

  14. Sato T, Kawase T, Yano H et al. Trans-tympanic silicone plug insertion for chronic patulous Eustachian tube. Acta Oto-Laryngol 2005;125:1158-63.

  15. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009:21;6.

  16. Scottish Intercollegiate Guidelines Network (SIGN) checklist for cohort studies. (30 May 2019).

  17. Schroder S, Lehmann M, Sudhoff HH et al. Treatment of the patulous Eustachian tube with soft-tissue bulking agent injections. Otol Neurotol 2015;36:448-52.

  18. Oh SJ, Lee IW, Goh EK et al. Trans-tympanic catheter insertion for treatment of patulous eustachian tube. Am J Otolaryngol Head Neck Med Surg 2015;36:748-52.

  19. Kikuchi T, Ikeda R, Oshima H et al. Effectiveness of Kobayashi plug for 252 ears with chronic patulous Eustachian tube. Acta Oto-Laryngol 2017;137:253-8.

  20. Yanez C, Pirron JA, Mora N. Curvature inversion technique: a novel tuboplastic technique for patulous Eustachian tube - a preliminary report. Otolaryngol Head Neck Surg 2011;145:446-51.

  21. Virtanen H, Palva T. Surgical treatment of patulous eustachian tube. Arch Otolaryngol 1982;108:735-9.

  22. Busato GM, Agrawal SK. Endoscopic ligation of the patulous eustachian tube as treatment for autophony. Laryngoscope 2013;123:239-43.

  23. Vaezeafshar R, Turner JH, Li G et al. Endoscopic hydroxyapatite augmentation for patulous eustachian tube. Laryngoscope 2014;124:62-6.

  24. Mackeith SAC, Bottrill ID. Polydimethylsiloxane elastomer injection in the management of the patulous eustachian tube. J Laryngol Otol 2016;130:805-10.

  25. Oh SJ, Lee IW, Goh EK et al. Endoscopic autologous cartilage injection for the patulous eustachian tube. American J Otolaryngol Head Neck Med Surg 2016;37:78-82.

  26. Jeong J, Nam J, Han SJ et al. Trans-tympanic cartilage chip insertion for intractable patulous Eustachian tube J Audiol Otol 2018;22:154-9.

  27. Alli A, Shukla R, Cook JL et al. A novel computed tomography guided, transcutaneous approach to treat refractory autophony in patients with a patulous Eustachian tube - a case series. J Laryngol Otol 2019;133:201-4

  28. Kim SJ, Shin SA, Lee HY et al. Paper patching for patulous eustachian tube. Acta Oto-laryngol 2019;139:122-8.

  29. Si Y, Chen Y, Li P et al. Eardrum thickening approach for the treatment of patulous Eustachian tube. Eur Arch Oto-Rhino-Laryngol 2016;273:3673-8.


Add new comment